97 related articles for article (PubMed ID: 10444197)
1. Infectious purpura fulminans: caution needed in the use of protein C.
Finn A; Booy R; Levin M; Nadel S; Faust S
Br J Haematol; 1999 Jul; 106(1):253-4. PubMed ID: 10444197
[No Abstract] [Full Text] [Related]
2. Replacement therapy with protein C concentrate in infants and adolescents with meningococcal sepsis and purpura fulminans.
Ettingshausen CE; Veldmann A; Beeg T; Schneider W; Jäger G; Kreuz W
Semin Thromb Hemost; 1999; 25(6):537-41. PubMed ID: 10632475
[TBL] [Abstract][Full Text] [Related]
3. Rapid recovery of acquired purpura fulminans in a patient with familial C4bBP deficiency.
Lemesle FG; Gris JC; Schwed JF; Arich C
Intensive Care Med; 1993; 19(2):115-6. PubMed ID: 8486865
[TBL] [Abstract][Full Text] [Related]
4. Myocarditis and purpura fulminans in meningococcaemia.
Gawalkar AA; Tale S; Chhabria BA; Bhalla A
QJM; 2017 Nov; 110(11):755-756. PubMed ID: 29024990
[No Abstract] [Full Text] [Related]
5. Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study.
de Kleijn ED; de Groot R; Hack CE; Mulder PG; Engl W; Moritz B; Joosten KF; Hazelzet JA
Crit Care Med; 2003 Jun; 31(6):1839-47. PubMed ID: 12794428
[TBL] [Abstract][Full Text] [Related]
6. Surgical intervention for the complications of meningococcal-induced purpura fulminans.
Herrera R; Hobar PC; Ginsburg CM
Pediatr Infect Dis J; 1994 Aug; 13(8):734-7. PubMed ID: 7970975
[TBL] [Abstract][Full Text] [Related]
7. Drotrecogin alfa (activated) for the treatment of meningococcal purpura fulminans.
Bachli EB; Vavricka SR; Walter RB; Leschinger MI; Maggiorini M
Intensive Care Med; 2003 Feb; 29(2):337. PubMed ID: 12594601
[No Abstract] [Full Text] [Related]
8. Treatment of purpura fulminans in meningococcemia with protein C concentrate.
Rivard GE; David M; Farrell C; Schwarz HP
J Pediatr; 1995 Apr; 126(4):646-52. PubMed ID: 7699550
[TBL] [Abstract][Full Text] [Related]
9. An ADAM-10 dependent EPCR shedding links meningococcal interaction with endothelial cells to purpura fulminans.
Lécuyer H; Virion Z; Barnier JP; Matczak S; Bourdoulous S; Bianchini E; Saller F; Borgel D; Nassif X; Coureuil M
PLoS Pathog; 2018 Apr; 14(4):e1006981. PubMed ID: 29630665
[TBL] [Abstract][Full Text] [Related]
10. Meningococcal purpura fulminans: treatment of vascular insufficiency in a 2-yr-old child with lumbar epidural sympathetic blockade.
Anderson CT; Berde CB; Sethna NF; Pribaz JJ
Anesthesiology; 1989 Sep; 71(3):463-4. PubMed ID: 2774279
[No Abstract] [Full Text] [Related]
11. Infectious purpura fulminans: diagnosis and treatment.
Smith OP; White B
Br J Haematol; 1999 Feb; 104(2):202-7. PubMed ID: 10050699
[No Abstract] [Full Text] [Related]
12. [Replacement therapy with protein C for meningococcal sepsis and fulminant purpura in pediatric patients].
Llinares Tello F; Hernández Prats C; Burgos San José A; Bosacoma Ros N; Alcalá Minagorre P; López Rodríguez F; Reig Sáenz R; Marco Vera P; Ordovás Baines JP
Farm Hosp; 2004; 28(2):130-6. PubMed ID: 15101805
[TBL] [Abstract][Full Text] [Related]
13. Replacement treatment with protein C in an 18-year-old man with meningococcal sepsis and purpura fulminans.
Vaccarella G; Pelella R
Minerva Anestesiol; 2003 Sep; 69(9):691-3, 693-5. PubMed ID: 14564239
[TBL] [Abstract][Full Text] [Related]
14. Epidemic meningococcemia and purpura fulminans with induced protein C deficiency.
Powars D; Larsen R; Johnson J; Hulbert T; Sun T; Patch MJ; Francis R; Chan L
Clin Infect Dis; 1993 Aug; 17(2):254-61. PubMed ID: 8399877
[TBL] [Abstract][Full Text] [Related]
15. Circulating nucleosomes and severity of illness in children suffering from meningococcal sepsis treated with protein C.
Zeerleder S; Stephan F; Emonts M; de Kleijn ED; Esmon CT; Varadi K; Hack CE; Hazelzet JA
Crit Care Med; 2012 Dec; 40(12):3224-9. PubMed ID: 22932399
[TBL] [Abstract][Full Text] [Related]
16. [Value of heparin in the treatment of meningococcal purpura fulminans. 3 cases].
Charlas J; Thieffry JC; Madelin JC; Dardenne P; Meyer B; Paupe J; Vialatte J
Ann Pediatr (Paris); 1970; 17(8):553-9. PubMed ID: 5455263
[No Abstract] [Full Text] [Related]
17. Meningococcal purpura fulminans treated with antithrombin III concentrate: what is the optimal replacement therapy?
Cobcroft R; Henderson A; Solano C; Scott D
Aust N Z J Med; 1994 Oct; 24(5):575-6. PubMed ID: 7848164
[No Abstract] [Full Text] [Related]
18. Meningococcal septicaemia: treatment with protein C concentrate.
Clarke RC; Johnston JR; Mayne EE
Intensive Care Med; 2000 Apr; 26(4):471-3. PubMed ID: 10872142
[TBL] [Abstract][Full Text] [Related]
19. Purpura fulminans during meningococcal sepsis treated with Drotrecogin alpha. A clinical case.
Belloni G; Ramello P; Salcuni MR; Scavone L; Girotto M; Di Bassiano F
Minerva Anestesiol; 2006 Apr; 72(4):249-54. PubMed ID: 16570037
[TBL] [Abstract][Full Text] [Related]
20. Milrinone in meningococcal sepsis.
Rich N; West N; McMaster P; Alexander J
Pediatr Crit Care Med; 2003 Jul; 4(3):394-5. PubMed ID: 12840611
[No Abstract] [Full Text] [Related]
[Next] [New Search]
